Last updated on February 2018

A Multi-center Randomized Double-blind Active-controlled Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: NIDDM | Dyslipidemia
  • Age: Between 19 - 80 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Subjects with Dyslipidemia and Type II Diabetes
  • 19 years later, men and women under the age of 80

Exclusion Criteria:

  • Pregnant women, nursing mothers or subject who does not agree to assigned contraception in the study
  • Subject with type I Diabetes
  • Subject with hypertension which does not controlled by treatment(have blood pressure > 180/110mmHg)

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.